INDP - Indaptus Therapeutics, Inc. Stock Price, Fair Value and News
2.40USD+0.13 (+5.73%)Market Closed
Latest Insider Trading transactions for INDP
| Datesorted ascending | Name | Buy/Sell | $ Value | # Shares | Avg. Price | Title |
|---|---|---|---|---|---|---|
| 2023-08-14 | Premium | bought | Premium | Premium | Premium | - |
| 2023-08-11 | Premium | bought | Premium | Premium | Premium | - |
| 2023-08-10 | Premium | bought | Premium | Premium | Premium | - |
| 2022-12-01 | Premium | bought | Premium | Premium | Premium | Chief Medical Officer |
| 2022-11-22 | Premium | bought | Premium | Premium | Premium | Chief Medical Officer |
| 2022-11-21 | Premium | bought | Premium | Premium | Premium | CEO and Director |
| 2022-11-18 | Premium | bought | Premium | Premium | Premium | CEO and Director |
| 2022-09-08 | Premium | bought | Premium | Premium | Premium | CEO and Director |
| 2022-09-07 | Premium | bought | Premium | Premium | Premium | CEO and Director |
| 2022-09-07 | Premium | bought | Premium | Premium | Premium | Chief Business Officer |
| 2022-09-06 | Premium | bought | Premium | Premium | Premium | CEO and Director |
| 2022-06-06 | Premium | bought | Premium | Premium | Premium | CEO and Director |
| 2022-03-02 | Premium | bought | Premium | Premium | Premium | Chief Medical Officer |
| 2022-02-01 | Premium | sold | Premium | Premium | Premium | CSO and Director |
| 2022-01-31 | Premium | sold | Premium | Premium | Premium | CSO and Director |
| 2022-01-31 | Premium | bought | Premium | Premium | Premium | Chief Medical Officer |
| 2021-11-18 | Premium | bought | Premium | Premium | Premium | CEO and Director |
| 2021-09-14 | Premium | bought | Premium | Premium | Premium | CEO and Director |